Results

Total Results: 80 records

Showing results for "psa".
Users also searched for: aspirin

61. Chapter 7: Grading a Body of Evidence on Diagnostic Tests | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-grading/methods
    December 01, 2019 - some tests that have continuous outcomes and possibly multiple cutoffs [e.g., gene expression, serum PSA … some tests that have continuous outcomes and possibly multiple cutoffs (e.g., gene expression, serum PSA

62. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/reporting.ppt
    September 01, 2009 - used watchful waiting , men with clinically localized prostate cancer detected by methods other than PSA … overall mortality appears to be limited to men under 65 years of age but is not dependent on baseline PSA

63. Cell-Free-Dna-Appendix-C (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c.xlsx
    September 01, 2024 - cancer], human epidermal growth factor receptor 2 [HER2; breast cancer], prostate-specific antigen [PSA … Yes OneTest Serum AFP, CA 15-3, CA125, PSA, SCC, CEA (until 4/12/2011), and CA19-9 (until 12/1/2009) … AFP 15 ng/ml, CA-125 35 U/ml, CA 15-3 30 U/ml, CA 19-9 37 U/ml, CEA 5 ng/ml, CYFRA 21-1 3.3 ng/ml, PSA … Protein (AFP; CA 125; CA 15-3; CA 19-9; CEA; CYFRA 21-1; PSA; SCC) Used commericial kits (Abbot Diagnostics … emission tomography-computed tomography POC probability of cancer PPV positive predictive value PSA

64. Chronic-urinary-retention-protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
    November 19, 2012 - include: • urinalysis (UA) • urine culture • measures of renal function • prostate-specific antigen (PSA

65. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - found that expanded coverage decreased the proportion of men with high prostate-specific antigen (PSA … The researchers estimated the difference between the proportion of men with high PSA scores after versus … For instance, a visual inspection of a graph of PSA trends for expansion and non-expansion states in

66. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - found that expanded coverage decreased the proportion of men with high prostate-specific antigen (PSA … The researchers estimated the difference between the proportion of men with high PSA scores after versus … For instance, a visual inspection of a graph of PSA trends for expansion and non-expansion states in

67. Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-draft-report.pdf
    December 01, 2024 - 41,516 (51,8% female) ages 20 to 93 years; Race/ethnicity NR Protein panel AFP, CA 15-3, CA 125, PSA … Results 16 reported; PSA = prostate-specific antigen; ROB = risk of bias; SCC = squamous cell specific … 41,516 adults in Taiwan, Wen et al. evaluated an eight protein marker panel (AFP, CA 15-3, CA 125, PSA … PMA Premarket Approval PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses PSA

68. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
    January 01, 2020 - gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA

69. Diagnosis of Celiac Disease | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/celiac-disease/research-protocol
    December 01, 2020 - some tests that have continuous outcomes and possibly multiple cutoffs [e.g., gene expression, serum PSA

70. Comparative Effectiveness of Approaches to Weight Maintenance in Adults | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/weight-gain-prevention/research-protocol
    December 01, 2019 - gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA

71. PowerPoint Presentation (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-strength-evidence.ppt
    June 01, 2012 - For example, serum levels of prostate-specific antigen (PSA) are reported as a number that will theoretically … This dose-response association can help support the use of serum PSA in detecting prostate cancer.

72. PowerPoint Presentation (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-strength-evidence.ppt
    June 01, 2012 - For example, serum levels of prostate-specific antigen (PSA) are reported as a number that will theoretically … This dose-response association can help support the use of serum PSA in detecting prostate cancer.

73. celiac-disease-protocol-140612 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/celiac-disease_research-protocol.pdf
    June 12, 2014 - some tests that have continuous outcomes and possibly multiple cutoffs [e.g., gene expression, serum PSA

74. Health Literacy Interventions and Outcomes: An Update of the Literacy and Health Outcomes Systematic Review of the Literature | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/health-literacy/research-protocol
    December 01, 2019 - "Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer."

75. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/health-literacy_research-protocol.pdf
    January 22, 2010 - Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.

76. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
    June 07, 2013 - The first is more a function of PSA which can be done with a Markov cohort model.

77. Weight-Gain-Prevention Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
    January 01, 2020 - gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA

78. Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/decision-models-guidance/methods
    April 01, 2021 - It is customary to use the term “probabilistic sensitivity analysis” (PSA) to refer to numerical propagation … We do not use the term PSA in this work to avoid confusion.

79. Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
    October 01, 2016 - It is customary to use the term “probabilistic sensitivity analysis” (PSA) to refer to numerical propagation … We do not use the term PSA in this work to avoid confusion.

80. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - before randomization, bladder surgery within 6 months, cancer, interstitial cystitis, men with PSA